[1] LIU S, HONG X, SHEN C, et al. Kabuki syndrome: a Chinese case series and systematic review of the spectrum of mutations. BMC Med Genet, 2015, 16: 26. [2] HANNIBAL M C, BUCKINGHAM K J, NG S B, et al. Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome. Am J Med Genet A, 2011, 155A(7): 1511-1516. [3] FROIMCHUK E, JANG Y, GE K. Histone H3 lysine 4 methyltransferase KMT2D. Gene, 2017, 627: 337-342. [4] Van LAARHOVEN P M, NEITZEL L R, QUINTANA A M, et al. Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development. Hum Mol Genet, 2015, 24(15): 4443-4453. [5] ANG S Y, UEBERSOHN A, SPENCER C I, et al. KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation. Development, 2016, 143(5): 810-821. [6] KIM D H, RHEE J C, YEO S, et al. Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice. Hepatology, 2015, 61(3): 1012-1023. [7] DENTICI M L, Di PEDE A, LEPRI F R, et al. Kabuki syndrome: clinical and molecular diagnosis in the first year of life. Arch Dis Child, 2015, 100(2): 158-164. [8] 杨琳, 董欣然, 彭小敏, 等. 复旦大学附属儿科医院高通量测序数据分析流程(第二版)对遗传疾病候选变异基因筛选用时和准确性分析. 中国循证儿科杂志, 2018, 13(2): 118-123. [9] STANGLER H , MARCUN V N, N K V, et al. De novo KMT2D heterozygous frameshift deletion in a newborn with a congenital heart anomaly. Balkan J Med Genet, 2020, 23(1): 83-90. [10] PIRO E, SCHIERZ I, ANTONA V, et al. Neonatal hyperinsulinemic hypoglycemia: case report of kabuki syndrome due to a novel KMT2D splicing-site mutation. Ital J Pediatr, 2020, 46(1): 136. [11] MSRLGIL M, YLDZ Y, AKN O, et al. A rare cause of hyperinsulinemic hypoglycemia: Kabuki syndrome. J Clin Res Pediatr Endocrinol, 2020, doi: 10. 4274/jcrpe. galenos. 2020. 2020. 0065. [12] HOERMANN H, EL-RIFAI O, SCHEBEK M, et al. Comparative meta-analysis of Kabuki syndrome with and without hyperinsulinaemic hypoglycaemia. Clin Endocrinol (Oxf), 2020, 93(3): 346-354. [13] PHETTHONG T, TIM-AROON T, KHONGKRAPAN A, et al. Kabuki syndrome with midgut malrotation and hyperinsulinemic hypoglycemia: A rare co-occurrence from Thailand. Am J Med Genet A, 2020, 182(8): 1873-1876. [14] BALDRIDGE D, SPILLMANN R C, WEGNER D J, et al. Phenotypic expansion of KMT2D-related disorder: Beyond Kabuki syndrome. Am J Med Genet A, 2020, 182(5): 1053-1065. [15] CUVERTINO S, HARTILL V, COLYER A, et al. A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome. Genet Med, 2020, 22(5): 867-877. [16] YAP C S, JAMUAR S S, LAI A, et al. Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders. Gene, 2020, 731: 144360. [17] WANG Y, LI N, SU Z, et al. The phenotypic spectrum of Kabuki syndrome in patients of Chinese descent: A case series. Am J Med Genet A, 2020, 182(4): 640-651. [18] DALY T, ROBERTS A, YANG E, et al. Holoprosencephaly in Kabuki syndrome. Am J Med Genet A, 2020, 182(3): 441-445. [19] LUPERCHIO T R, APPLEGATE C D, BODAMER O, et al. Haploinsufficiency of KMT2D is sufficient to cause Kabuki syndrome and is compatible with life. Mol Genet Genomic Med, 2020, 8(2): e1072. [20] AREF-ESHGHI E, BOURQUE D K, KERKHOF J, et al. Genome-wide DNA methylation and RNA analyses enable reclassification of two variants of uncertain significance in a patient with clinical Kabuki syndrome. Hum Mutat, 2019, 40(10): 1684-1689. [21] GEERS N C, THIO H B, de KORT W. Capillary malformations in a child with Kabuki syndrome: A case report. JAAD Case Rep, 2019, 5(6): 560-562. [22] LIN P A, TSENG S H, LAI I W, et al. Bilateral congenital corneal opacities as an early-onset ocular feature of Kabuki syndrome. Cornea, 2019, 38(9): 1182-1184. [23] ARSOV T, SESTAN M, CEKADA N, et al. Systemic lupus erythematosus: A new autoimmune disorder in Kabuki syndrome. Eur J Med Genet, 2019, 62(6): 103538. [24] MOON J E, LEE S J, KO C W. A de novo KMT2D mutation in a girl with Kabuki syndrome associated with endocrine symptoms: a case report. BMC Med Genet, 2018, 19(1): 102. [25] TERANISHI H, KOGA Y, NAKASHIMA K, et al. Cancer management in Kabuki syndrome: The first case of Wilms tumor and a literature review. J Pediatr Hematol Oncol, 2018, 40(5): 391-394. [26] SAKATA S, OKADA S, AOYAMA K, et al. Individual clinically diagnosed with CHARGE syndrome but with a mutation in KMT2D, a gene associated with Kabuki Syndrome: A case report. Front Genet, 2017, 8: 210. [27] LEPRI F R, COCCIADIFERRO D, AUGELLO B, et al. Clinical and neurobehavioral features of three novel Kabuki syndrome patients with mosaic KMT2D mutations and a review of literature. Int J Mol Sci, 2017, 19(1): 82. [28] TOPA A, SAMUELSSON L, LOVMAR L, et al. On the significance of craniosynostosis in a case of Kabuki syndrome with a concomitant KMT2D mutation and 3. 2 Mbp de novo 10q22. 3q23. 1 deletion. Am J Med Genet A, 2017, 173(8): 2219-2225. [29] LEHMAN N, MAZERY A C, VISIER A, et al. Molecular, clinical and neuropsychological study in 31 patients with Kabuki syndrome and KMT2D mutations. Clin Genet, 2017, 92(3): 298-305. [30] HAANPÄÄ M, SCHLECHT H, BATRA G, et al. Interrupted/bipartite clavicle as a diagnostic clue in Kabuki syndrome. Am J Med Genet A, 2017, 173(4): 1115-1118. [31] GOLE H, CHUK R, COMAN D. Persistent hyperinsulinism in Kabuki syndrome 2: Case report and literature review. Clin Pract, 2016, 6(3): 848. [32] LU J, MO G, LING Y, et al. A novel KMT2D mutation resulting in Kabuki syndrome: A case report. Mol Med Rep, 2016, 14(4): 3641-3645. [33] LONG A, SINKOVSKAYA E S, EDMONDSON A C, et al. Kabuki syndrome as a cause of non-immune fetal hydrops/ascites. Am J Med Genet A, 2016, 170(12): 3333-3337. [34] BÖGERSHAUSEN N, ALTUNOGLU U, BELEGGIA F, et al. An unusual presentation of Kabuki syndrome with orbital cysts, microphthalmia, and cholestasis with bile duct paucity. Am J Med Genet A, 2016, 170(12): 3282-3288. [35] PADÉROVÁ J, HOLUBOVÁA, SIMANDLOVÁ M, et al. Molecular genetic analysis in 14 Czech Kabuki syndrome patients is confirming the utility of phenotypic scoring. Clin Genet, 2016, 90(3): 230-237. [36] ROMA D, PALMA P, CAPOLINO R, et al. Spinal ependymoma in a patient with Kabuki syndrome: a case report. BMC Med Genet, 2015, 16: 80. [37] GOHDA Y, OKA S, MATSUNAGA T, et al. Neonatal case of novel KMT2D mutation in Kabuki syndrome with severe hypoglycemia. Pediatr Int, 2015, 57(4): 726-728. [38] LIN J L, LEE W I, HUANG J L, et al. Immunologic assessment and KMT2D mutation detection in Kabuki syndrome. Clin Genet, 2015, 88(3): 255-260. [39] CHEON C K, SOHN Y B, KO J M, et al. Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome. J Hum Genet, 2014, 59(6): 321-325. [40] SCHULZ Y, FREESE L, MÄNZ J, et al. CHARGE and Kabuki syndromes: a phenotypic and molecular link. Hum Mol Genet, 2014, 23(16): 4396-4405. [41] CAPPUCCIO G, ROSSI A, FONTANA P, et al. Bronchial isomerism in a Kabuki syndrome patient with a novel mutation in MLL2 gene. BMC Med Genet, 2014, 15: 15. [42] GIORDANO P, LASSANDRO G, SANGERARDI M, et al. Autoimmune haematological disorders in two Italian children with Kabuki syndrome. Ital J Pediatr, 2014, 40: 10. [43] SUBBARAYAN A, HUSSAIN K. Hypoglycemia in Kabuki syndrome. Am J Med Genet A, 2014, 164A(2): 467-471. [44] MIYAKE N, KOSHIMIZU E, OKAMOTO N, et al. MLL2 and KDM6A mutations in patients with Kabuki syndrome. Am J Med Genet A, 2013, 161A(9): 2234-2243. [45] MAKRYTHANASIS P, van BON B W, STEEHOUWER M, et al. MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study. Clin Genet, 2013, 84(6): 539-545. [46] BRACKMANN F, KRUMBHOLZ M, LANGER T, et al. Novel MLL2 mutation in Kabuki syndrome with hypogammaglobulinemia and severe chronic thrombopenia. J Pediatr Hematol Oncol, 2013, 35(7): e314-e316. [47] BANKA S, HOWARD E, BUNSTONE S, et al. MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome. Clin Genet, 2013, 83(5): 467-471. [48] KOKITSU-NAKATA N M, PETRIN A L, HEARD J P, et al. Analysis of MLL2 gene in the first Brazilian family with Kabuki syndrome. Am J Med Genet A, 2012, 158A(8): 2003-2008. [49] BANKA S, VEERAMACHANENI R, REARDON W, et al. How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum. Eur J Hum Genet, 2012, 20(4): 381-388. [50] LI Y, BÖGERSHAUSEN N, ALANAY Y, et al. A mutation screen in patients with Kabuki syndrome. Hum Genet, 2011, 130(6): 715-724. [51] PAULUSSEN A D, STEGMANN A P, BLOK M J, et al. MLL2 mutation spectrum in 45 patients with Kabuki syndrome. Hum Mutat, 2011, 32(2): E2018-E2025. [52] 李洁玲, 曹洁. Kabuki综合征2例报告. 临床儿科杂志, 2018, 36(1): 53-56. [53] 张含滋, 陈倩, 姬辛娜, 等. Kabuki综合征伴癫痫2例报告. 神经疾病与精神卫生, 2019, 19(1): 102-105. [54] 王红梅, 王晓慧, 吴沪生, 等. Kabuki综合征临床和实验室特点及基因诊断. 中华儿科杂志, 2018, 56(11): 846-849. [55] 陈艳丽, 陶长忠. KMT2D基因突变所致Kabuki综合征1例报告并文献复习. 基层医学论坛, 2020, 24(4): 460-462. [56] 杨桂花, 孙艳芳, 李慧源, 等. KMT2D基因新发变异致Kabuki综合征1例报告. 临床儿科杂志, 2020, 38(6): 467-471. [57] 邱士伟, 袁永一. KMT2D基因致病新变异引起的Kabuki综合征的耳聋表型分析. 临床耳鼻咽喉头颈外科杂志, 2019, 33(9): 820-824. [58] 陶雪花, 张士发, 唐宗生. 歌舞伎综合征KMT2D基因型1例. 皖南医学院学报, 2020, 39(5): 508-510. [59] 上官华坤, 苏畅, 巩纯秀, 等. KMT2D或KDM6A基因突变致歌舞伎综合征4例并文献复习. 中华实用儿科临床杂志, 2019(22): 1738-1739. [60] 代晓微, 郑连文, 徐影, 等. 一例歌舞伎化妆综合征(Kabuki Syndrome)患儿的病例及遗传学分析. 中国优生与遗传杂志, 2018, 26(2): 85-86. [61] 凌晨, 徐慧, 刘金荣, 等. 婴儿期歌舞伎脸谱综合征1例. 中华实用儿科临床杂志, 2016(2): 156-157. [62] ADAM M P, BANKA S, BJORNSSON H T, et al. Kabuki syndrome: international consensus diagnostic criteria. J Med Genet, 2019, 56(2): 89-95. |